Expression of anti-microbial defense factors in vaginal mucosa following exposure to Lactobacillus rhamnosus GR-1

International Journal of Probiotics and Prebiotics

Volumn 3, Issue 2, 2008, Pages 99-106

  Kirjavainen, Pirkka V ^a,b   Laine, Riikka M ^a   Carter, David E ^c   Hammond, Jo Anne ^d   Reid, Gregor ^a,d  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Gene expression; Lactobacilli; Probiotic; Vagina

Indexed keywords

CASPASE 8; CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 8; MUCIN 4; PATTERN RECOGNITION RECEPTOR; PEPTIDE DERIVATIVE; PROBIOTIC AGENT; PSORIASIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LACTOBACILLUS RHAMNOSUS; LYMPHOCYTE ACTIVATION; MICROARRAY ANALYSIS; MORNING DOSAGE; NONHUMAN; OUTCOME ASSESSMENT; RNA ANALYSIS; RNA EXTRACTION; SINGLE DRUG DOSE; TREATMENT DURATION; UPREGULATION; VAGINA MUCOSA; VAGINITIS;

EID: 52649113813     PISSN: 15551431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, and Reid G. (2006) Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes and Infection 8: 2772-6.
2. Aroutcheva A, Gariti D, Simon M, Short S, Faro J, Simoes JA, Gurguis A, and Faro S. (2001) Defense factors of vaginal lactobacilli. American Journal of Obstetrics & Gynecology 185:375-379.
3. Boerma M, Burton GR, Wang J, Fink LM, McGehee RE, Jr, and Hauer-Jensen M. (2006) Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition. Blood Coagulation and Fibrinolysis 17:173-180.
4. Boskey ER, Telsch KM, Whaley KJ, Moench TR, and Cone RA. (1999) Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infection and Immunity 67:5170-55.
5. Chen B, Wen Y, Zhang Z, Guo Y, Warrington JA, and Polan ML. (2006) Microarray analysis of differentially expressed genes in vaginal tissues from women with stress urinary incontinence compared with asymptomatic women. Human Reproduction 21:22-9.
6. Coussens LM, and Werb Z. (2002) Inflammation and cancer. Nature 420:860-7.
7. Cremel M, Berlier W, Hamzeh H, Cognasse F, Lawrence P, Genin C, Bernengo J-C, Lambert C, Dieu-Nosjean M.-C, and Delezay O. (2005) Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction. Journal of Leukocyte Biology 78:158-166.
8. Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, Winter C, Meier A, and Stamm WE. (2000) Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clinical Infectious Disease 30:901-7.
9. Fazeli A, Bruce C, and Anumba DO. (2005) Characterization of Toll-like receptors in the female reproductive tract in humans. Human Reproduction 20:1372-1378.
10. Fichorova RN, and Anderson DJ. (1999) Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biology of Reproduction 60:508-14.
11. Fichorova R, Rheinwald J, and Anderson D. (1997) Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biology of Reproducton 157:847-855.
12. Forchielli ML, and Walker WA. (2005) The role of gut-associated lymphoid tissues and mucosal defence. British Journal of nutrition 93 Suppl 1:LS41-8.
13. Habis AH, Vernon SD, Lee DR, Verma M, and Unger ER. (2004) Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiology Biomarkers & Prevention 13:492-496.
14. Hedges SR, Barrientes F, Desmond RA, and Schwebke JR. (2006) Local and systemic cytokine levels in relation to changes in vaginal flora. The Journal of Infectious Diseases 193:556-562.
15. Iigo M, Shimamura M, Matsuda E, Fujita K, Nomoto H, Satoh J, Kojima S, Alexander DB, Moore MA, and Tsuda H. (2004) Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. Cytokine 25:36-44.
16. Jones C, Simpson P, Mackay A, and Lakhani SR. (2006) Expression profiling using cDNA microarrays. Methods in Molecular Medicine 120:403-14.
17. Keane FE, Ison CA, and Taylor-Robinson D. (1997) A longitudinal study of the vaginal flora over a menstrual cycle. International Journal of STD & AIDS 8:489-94.
18. Kim SO, Sheikh HI, Ha SD, Martins A, and Reid G. (2006) GCSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cellular Microbiology 8:1958-71.
19. Lee KC, and Eckert RL. (2007) S100A7 (Psoriasin) - mechanism of antibacterial action in wounds. Journal of Investigative Dermatology 127:945-57.
20. Lomako J, Lomako WM, and Whelan WJ. (2004) Glycogenin: the primer for mammalian and yeast glycogen synthesis. Biochimica et Biophysica Acta 1673:45-55.
21. Mack DR, Michail S, Wei S, McDougall L, and Hollingsworth MA. (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. American Journal of Physiology 276 (4 Pt 1):G941-50.
22. MacNeill C, Umstead TM, Phelps DS, Lin Z, Floros J, Shearer DA, and Weisz J. (2004) Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid. Immunology 111:91-9.
23. McNicholl JM, and Promadej N. (2004) Insights into the role of host genetic and T-cell factors in resistance to HIV transmission from studies of highly HIV-exposed Thais. Immunologic Research 29:161-74.
24. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, and Strominger JL. (1999) Human CD16 as alysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences USA 6:5640-4.
25. Marelli G, Papaleo E, and Ferrari A. (2004) Lactobacilli for prevention of urogenital infections: a review. European Review For Medical And Pharmacological Sciences 8:87-95.
26. Martinez-Anton A, Debolos C, Garrido M, Roca-Ferrer J, Barranco C, Alobid I, Xaubet A, Picado C, and Mullol J. (2006) Mucin genes have different expression patterns in healthy and diseased upper airway mucosa. Clinical & Experimental Allergy 36:448-57.
27. Milligan GN, Bourne N, and Dudley KL. (2001) Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina. Journal of Reproductive Immunology 49:49-65.
28. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, and Nakamura Y. (2001) Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Research 61:2129-37.
29. Peterson ML, Ault K, Kremer MJ, Klingelhutz AJ, Davis CC, Squier CA, and Schlievert PA. (2005) The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infection and Immunity 73:2164-74.
30. Pfundt R, van Ruissen F, van Vlijmen-Willems JMJJ, Alkemade HAC, Zeeuwen PLJM, Jap PH, Dijkman H, Fransen J, Croes H, van Erp PEJ, and Schalkwijk J. (1996) Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense inhuman epithelia. The Journal of Clinical Investigation 98:1389-1399.
31. Pivarcsi A, Nagy I, Koreck A, Kis K, Kenderessy-Szabo A, Szell M, Dobozy A, Kemeny L. (2005) Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human & β-defensin-2 in vaginal epithelial cells. Microbes and Infection 7:1117-1127.
32. Reid G, and Bruce AW. (2006) Probiotics to prevent urinary tract infections: the rationale and evidence. World Journal of Urology 24: 28-32.
33. Reid G, and Burton J. (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes and Infection 4:319-324.
34. Reid G, Burton J, Hammond J.-A, and Bruce AW. (2004) Nucleic acid based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. Journal of Medicinal Food 7: 223-228.
35. Reid G, Kim SO, and Kohler GA. (2006) Selecting, testing and understanding probiotic microorganisms. FEMS Immunology and Medical Microbiology 46:149-57.
36. Rhee SG, Chae HZ, and Kim K. (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radical Biology & Medicine 2005, 38:1543-52.
37. Schwebke JR, and Weiss H. (2001) Influence of the normal menstrual cycle on vaginal microflora. Clinical Infectious Diseases 32:325.
38. Simhan HN, Caritis SN, Krohn MA, and Hillier SL. (2003) Elevated vaginal pH and neutrophils are associated strongly with early spontaneous preterm birth. American Journal of Obstetrics and Gynecology 89:1150-1154.
39. Su H, Bidere N, Zheng L, Cubre A, Sakai K, Date J, Salmena L, Hakem R, Straus S, and Leonardo M. (2005) Requirement for caspase-8 in NF-kappa-B activation by antigen receptor. Science 307:1465-1468.
40. Vallor AC, Antonio MA, Hawes SE, and Hilher SL (2001) Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. Journal of Infectious Diseases 184:1431-6.
41. Viljanen M, Pohjavuori E, Haahtela T, Korpela. R, Kuitunen M, Sarnesto A, Vaarala O, and Savilahti E. (2005) Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. Journal of Allergy and Clinical Immunology 115:1254-9.
42. Wang J, Robinson JF, Khan HM, Carter DE, McKinney J, Miskie BA, and Hegele, RA. (2004) Optimizing RNA extraction yield from whole blood for microarray gene expression analysis. Clinical Biochemistry 37:741-4.
43. WHO. (2003) Guidelines for the management of sexually transmitted infections. World Health Organization.
44. Wicherek L, Mak P, Klimek M, and Banas, T. (2007) The length of menstrual bleeding and the risk of urogenital infections in the context of the activity of hemoglobin-derived microbicidal peptides. European Journal of Obstetrics & Gynecology and Reproductive Biology 131:97-100.
45. Wira CR, Fahey JV. (2004) The innate immune system: gatekeeper to the female reproductive tract. Immunology 111:13-5.